PE firm Gimv has upped its stake in German buy-and-build dental platform Gesellschaft für Praxisnachfolge in der Zahnmedizin (GPNZ). The market is the most fragmented in Europe.
Synlab's shares have continued to trade in the lower end of the IPO price range since it took to the Frankfurt Stock Exchange last Friday, April 30, opening flat and now around 3% up.
Margins for some of the largest French imaging operators halved from 2015 to 2019, after tariffs cuts in 2017, while the combined figure at the top 30 fell 2.4 percentage points.
EU countries have already earmarked over €47bn euros to spend on health care from the €672bn Recovery and Resilience Facility (RRF), the continent's centrepiece of COVID-19 recovery. Digital innovation, primary care and long-term care are clear spending priorities across the board. We should know the full allocations next week.
Life Healthcare's international division continued to make up for its sluggish core South African (SA) market in the last two quarters meaning it expects better results than SA-only competitor Netcare. German group Asklepios, the largest single-country hospital operator in Europe, saw a big loss in 2020 despite generous state support.
Ramsay Santé, the European arm of global hospital group Ramsay Health Care, has refinanced its €1.65bn syndicated debt and introduced an environmental, social and governance (ESG) component for the first time. The interest rate is eye-wateringly low for an S&P BB- rated issue, reflecting the backing that Ramsay Santé enjoys from the French government.
The European Centre for Disease Prevention and Control has awarded Eurofins a €48m whole-genome sequencing (WGS) contract for COVID-19 variant testing. The move demonstrates confidence that countries will be running high volumes of COVID-19 testing in the mid to long term.
Italy's largest hospital group San Donato is bidding to make its first move out of northern Italy through a binding offer for Rome's Fatebenefratelli hospital. Another Vatican-owned hospital is trying to shut down sale rumours at a time when many are struggling with the financial fallout from the pandemic.
The largest French hospital groups are looking at a new acquisition target with revenues of €76m and Almaviva Santé has just bought smaller rival Maymard. The moves come as ambulatory care accelerated four times faster than expected for one provider last year.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
